Stock Market Reviews

LFST (LifeStance Health Group, Inc.) News

Get the latest news, insights, and market updates on LFST (LifeStance Health Group, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 3 Cash-Producing Stocks with Warning Signs
  While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
  Feb 17, 2026 - $LFST
• LifeStance Health Group (LFST) Valuation Check After Mixed Short And Long Term Share Performance
  What recent performance says about LifeStance Health Group (LFST) LifeStance Health Group (LFST) has drawn investor attention after a mixed stretch, with a small gain over the past week, a decline over the past month, and a stronger move over the past 3 months. Over 1 year, the stock shows a negative total return, while the 3 year total return figure is positive, giving investors a contrasting picture of shorter versus longer term performance. See our latest analysis for LifeStance Health...
  Feb 15, 2026 - $LFST
• Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know
  A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a key measure of inflation, rose by 0.2%, which was less than economists had forecast, with the annual rate cooling to 2.4%. This encouraging data increased market expectations for the Fed to begin cutting interest rates as early as June. The news prompted a rally in Treasuries as their yields fell. Wh
  Feb 13, 2026 - $LFST
• 2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 That Underwhelm
  Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
  Feb 12, 2026 - $LFST
• LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026
  SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871,
  Feb 9, 2026 - $LFST
• DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates
  DaVita HealthCare (DVA) delivered earnings and revenue surprises of +5.08% and +2.69%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
  Feb 2, 2026 - $LFST
• 3 Small-Cap Stocks We’re Skeptical Of
  Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
  Jan 30, 2026 - $LFST
• Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes
  We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. LifeStance Health Group, Inc. (NASDAQ:LFST) is among the high growth stocks. TheFly reported on January 8 that KeyBanc analyst Steve Dechert increased the price target for LFST from $6.50 to $8.50, keeping an Overweight rating on the stock. KeyBanc described this period as […]
  Jan 22, 2026 - $LFST
• A Look At LifeStance Health Group (LFST) Valuation After Its Recent Share Price Momentum
  Event context and recent share performance LifeStance Health Group (LFST) has caught investor attention after a strong move in the share price over the past 3 months. This has prompted fresh questions about how its current valuation lines up with the business. See our latest analysis for LifeStance Health Group. At a share price of $7.40, LifeStance Health Group’s recent 90 day share price return of 45.38% and year to date share price return of 6.32% point to building momentum, even though...
  Jan 12, 2026 - $LFST
• 3 Low-Volatility Stocks That Concern Us
  Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
  Jan 2, 2026 - $LFST